Domenico Accili

Domenico Accili

Auto-generated profile, based on publicly available information

Domenico Accili

Department of Medicine, Vagelos College of Physicians and Surgeons of Columbia University, New York, USA

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Cell
Verified
Journal Article
Closed access
CTChutima Talchai
Chutima Talchai
SXShouhong Xuan
Shouhong Xuan
HLHua V. Lin
Hua V. Lin
LSLori Sussel
Lori Sussel
DADomenico Accili
Domenico Accili

1 May 2004 in Cell
Verified
Journal Article
Closed access
DADomenico Accili
Domenico Accili
KAKaren C Arden
Karen C Arden

1 August 2012 in Cell
Verified
Journal Article
Closed access
QLQiang Li
Qiang Li
LWLiheng Wang
Liheng Wang
NKNing Kon
Ning Kon
WZWenhui Zhao
Wenhui Zhao
SLSangkyu Lee
Sangkyu Lee
DADomenico Accili
Domenico Accili

4 October 2017 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
PDF file
RHRebecca A. Haeusler
Rebecca A. Haeusler
TMTimothy E. McGraw
Timothy E. McGraw
DADomenico Accili
Domenico Accili

1 October 2008 in Cell Metabolism
Verified
Journal Article
Closed access
ABAlex Banks
Alex Banks
NKNing Kon
Ning Kon
CKColette Knight
Colette Knight
MMMichihiro Matsumoto
Michihiro Matsumoto
RGRoger Gutiérrez-Juárez
Roger Gutiérrez-Juárez
DADomenico Accili
Domenico Accili

1 March 2016 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
FCFrancesca Cinti
Francesca Cinti
RBRyotaro Bouchi
Ryotaro Bouchi
JKJa Young Kim-Muller
Ja Young Kim-Muller
YOYoshiaki Ohmura
Yoshiaki Ohmura
PSP. R. Sandoval
P. R. Sandoval
DADomenico Accili
Domenico Accili
Context: Diabetes is associated with a deficit of insulin-producing β-cells. Animal studies show that β-cells become dedifferentiated in diabetes, reverting to a progenitor-like stage, and partly converting to other endocrine cell types. Objective: To determine whether similar processes occur in human type 2 diabetes, we surveyed pancreatic islets from 15 diabetic and 15 nondiabetic organ donors. Design: We scored dedifferentiation using markers of endocrine lineage, β-cell-specific transcription factors, and a newly identified endocrine progenitor cell marker, aldehyde dehydrogenase 1A3. Results: By these criteria, dedifferentiated cells accounted for 31.9% of β-cells in type 2 diabetics vs 8.7% in controls, and for 16.8% vs 6.5% of all endocrine cells (P < .001). The number of aldehyde dehydrogenase 1A3-positive/hormone-negative cells was 3-fold higher in diabetics compared with controls. Moreover, β-cell-specific transcription factors were ectopically found in glucagon- and somatostatin-producing cells of diabetic subjects. Conclusions: The data support the view that pancreatic β-cells become dedifferentiated and convert to α- and δ-“like” cells in human type 2 diabetes. The findings should prompt a reassessment of goals in the prevention and treatment of β-cell dysfunction.